Alex J. Szubert

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · The Lancet · 2010 · 571 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

James Hakim, Victor Musiime, Alex J. Szubert et al. · New England Journal of Medicine · 2017 · 224 citations · Full text

Public Health, Infectious Diseases, Pharmacotherapy +17

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

Gareth J. Morgan, J. Anthony Child, Walter M. Gregory et al. · The Lancet Oncology · 2011 · 163 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Effects of induction and maintenance plus long-term bisphosphonates on bone disease in patients with multiple myeloma: the Medical Research Council Myeloma IX Trial

Gareth J. Morgan, Faith E. Davies, Walter M. Gregory et al. · Blood · 2012 · 130 citations · Full text

Medicine, Oncology, Bone Metabolism +12